Walk away from memory loss: exercise trial for kidney patients
NCT ID NCT07160959
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a simple home exercise program can prevent memory and thinking problems from getting worse in people with advanced chronic kidney disease (stages 4-5). 124 participants will either do low-intensity walking and strength exercises or receive standard care. The goal is to find an easy, drug-free way to protect brain health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
home-based low-intensity interval exercise program (walking and strength training)
What this could lead to
If it works, this could offer a simple, drug-free way to protect brain function in people with advanced kidney disease.
What could go wrong
This is a small, early-stage trial (124 people) testing a behavioral intervention, so results may not be generalizable. Exercise adherence at home may be low, and cognitive benefits are uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE STAGE 5 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assistance Publique - Hôpitaux de Paris (AP-HP), Division of Geriatry
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Biogem
Ariano Irpino, 83031, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
-
Lithuanian University of Health Sciences
Kaunas, Lithuania
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Medical University of Warsaw, Department of Nephrology, Dialysis and Internal Medicine
Warsaw, Poland
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Medical Center Groningen, Department of Nephrology
Groningen, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
University of Zurich
Zurich, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••